白细胞介素-17在类风湿关节炎发病机制中的作用进展

被引：22

作者：

王秋燚

张小玲

宁乔怡

姚血明

马武开

机构：

[1] 贵阳中医学院第二附属医院

来源：

风湿病与关节炎 | 2017年 / 6卷 / 05期

关键词：

关节炎,类风湿; IL-17; 炎症; 关节破坏; 综述;

D O I：

暂无

中图分类号：

R593.22 [类风湿性关节炎];

学科分类号：

100201 [内科学];

摘要：

白细胞介素-17(IL-17)是一种新近发现的重要的前炎症细胞因子,其在类风湿关节炎患者体内高度表达,提示IL-17与类风湿关节炎有密切关系。综述IL-17在类风湿关节炎发病中的特点、促炎作用、对关节破坏以及治疗等方面的研究进展。

引用

页码：68 / 72

页数：5

共 24 条

[1]

Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage [J].

Schminke, Boris ;

Trautmann, Sandra ;

Mai, Burkhard ;

Miosge, Nicolai ;

Blaschke, Sabine .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (02) :440-445

[2]

Interleukin-17 and innate immunity in infections and chronic inflammation.[J].Natasa Isailovic;Kenji Daigo;Alberto Mantovani;Carlo Selmi.Journal of Autoimmunity.2015,

[3]

Combined Inhibition of Tumor Necrosis Factor α and Interleukin-17 As a Therapeutic Opportunity in Rheumatoid Arthritis Development and Characterization of a Novel Bispecific Antibody [J].

Fischer, Jens A. A. ;

Hueber, Axel J. ;

Wilson, Stacy ;

Galm, Margarete ;

Baum, Wolfgang ;

Kitson, Christopher ;

Auer, Johannes ;

Lorenz, Stefan H. ;

Moelleken, Joerg ;

Bader, Martin ;

Tissot, Alain C. ;

Tan, Seng-Lai ;

Seeber, Stefan ;

Schett, Georg .

ARTHRITIS & RHEUMATOLOGY, 2015, 67 (01) :51-62

[4]

A Phase II Randomized Study of Subcutaneous Ixekizumab; an Anti–Interleukin‐17 Monoclonal Antibody; in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors<link href="#art38617-note-0001"/>.[J].Mark C. Genovese;Maria Greenwald;Chul‐Soo Cho;Alberto Berman;Ling Jin;Gregory S. Cameron;Olivier Benichou;Li Xie;Daniel Braun;Pierre‐Yves Berclaz;Subhashis Banerjee.Arthritis & Rheumatology.2014, 7

[5]

Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients [J].